Novel missense mutation in VPS33B is associated with isolated low gamma‐glutamyltransferase cholestasis: Attenuated, incomplete phenotype of arthrogryposis, renal dysfunction, and cholestasis syndrome
- 3 September 2019
- journal article
- research article
- Published by Wiley in Human Mutation
- Vol. 40 (12) , 2247-2257
Abstract
The typical phenotype of arthrogryposis, renal dysfunction, and cholestasis (ARC) syndrome involves three cardinal symptoms as the name describes, harboring biallelic mutations on VPS33B or VIPAS39. Except for ARC syndrome, low gamma‐glutamyltransferase (GGT) cholestasis often implies hereditary hepatopathy of different severity; however, some remain undiagnosed. Several monogenic defects typically with multiorgan manifestations may only present liver dysfunction at times, such as DGUOK defect and AGL defect. Previously, four VPS33B mutated cases were reported without arthrogryposis, or with less severe symptoms and longer lifespan, indicating the possibility of incomplete ARC phenotype of isolated hepatopathy. So we retrospectively reviewed all patients with confirmed VPS33B/VIPARS39 defect in our center and identified three presenting isolated low‐GGT cholestasis with intractable pruritus. Distinguished from others with typical ARC phenotype, these patients did not suffer the other two typical characteristics, survived much longer, and shared a novel missense VPS33B variation c.1726T>C, p.Cys576Arg, causing declined protein expression and abolished interaction with VIPAS39 in‐vitro. Serum bile acid profiles of our VPS33B/VIPAS39 mutated patients revealed similar changes to primary defect of bile salt export pump, among which those with isolated cholestasis phenotype had a higher level of total secondary bile acids than that with typical ARC phenotype, indicating the partial residual function of VPS33B.Keywords
Funding Information
- National Natural Science Foundation of China (81570468, 81361128006, 81741056)
This publication has 27 references indexed in Scilit:
- Progressive Familial Intrahepatic CholestasisClinics in Liver Disease, 2018
- Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseasesJournal of Biomedical Science, 2018
- VPS33B regulates protein sorting into and maturation of α-granule progenitor organelles in mouse megakaryocytesBlood, 2015
- Arthrogryposis, Renal Dysfunction, and Cholestasis Syndrome Caused By VIPAR MutationJournal of Pediatric Gastroenterology and Nutrition, 2014
- Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarizationNature Genetics, 2010
- Arc syndrome without arthrogryposis, with hip dislocation and renal glomerulocystic appearance: a case reportEuropean Journal of Pediatrics, 2008
- Molecular investigations to improve diagnostic accuracy in patients with ARC syndromeHuman Mutation, 2008
- Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinaseHuman Mutation, 2008
- VPS33B mutation with ichthyosis, cholestasis, and renal dysfunction but without arthrogryposis: Incomplete ARC syndrome phenotypeThe Journal of Pediatrics, 2006
- Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis–renal dysfunction–cholestasis (ARC) syndromeNature Genetics, 2004